← Leaderboards
Sudhir Sahasrabudhe
Jsk Therapeutics, Inc.
$309,189
Attributed
$927,566
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$927,566 · 1
By mechanism
R44$927,566 · 1
Top collaborators
- Thomas Preston Kennedy1 shared
- Paul J Shami1 shared
Most similar at Jsk Therapeutics, Inc.
Same institution · by research overlap
- Gregory John Johnson$87,519
- Joseph Felix Nowoslawski$1,998,606
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAnimalsAnticancer ActivityAntineoplastic AgentsAqueousBacteriaBaseBone MarrowBone Marrow CellsCancer CellCancer PatientCancer TherapyCanis FamiliarisCapital FinancingCardiovascular SystemCellsChemistryChromosome AbnormalityChronicCitiesClinical TrialsCollaborationsCollegeAchievement